{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:52:30Z","timestamp":1793170350738,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-23-IAHU-007"],"award-info":[{"award-number":["ANR-23-IAHU-007"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-LABX-0028-01"],"award-info":[{"award-number":["ANR-11-LABX-0028-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-15-IDEX-01"],"award-info":[{"award-number":["ANR-15-IDEX-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014182","name":"Cancerop\u00f4le Provence-Alpes-C\u00f4te d'Azur","doi-asserted-by":"publisher","award":["Prematuration EmA"],"award-info":[{"award-number":["Prematuration EmA"]}],"id":[{"id":"10.13039\/501100014182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["Innovation"],"award-info":[{"award-number":["Innovation"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019899","name":"Alliance Nationale pour les Sciences de la Vie et de la Sant\u00e9","doi-asserted-by":"publisher","award":["2021- 2030 Cancer Control Strategy"],"award-info":[{"award-number":["2021- 2030 Cancer Control Strategy"]}],"id":[{"id":"10.13039\/100019899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["IMoDRez,18CB001-00"],"award-info":[{"award-number":["IMoDRez,18CB001-00"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["Cellema,22CM045-00"],"award-info":[{"award-number":["Cellema,22CM045-00"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Syst Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Drug-tolerant cells to pro-apoptotic treatments exhibit transient resistance to subsequent challenges, which can be sustained via transcriptional and translational regulations. Although persister cells have been described in other cell death modalities, how they respond to subsequent treatments that are different from the one they originate from remains less explored. Here we show that drug-tolerant cells to pro-apoptotic treatments exhibit a reduced capacity to activate caspase-8, as well as higher levels of RIPK3 protein expression. As this apoptosis-tolerant cell state exhibits features of vulnerability to necroptosis, we show that alternating from apoptotic to necroptotic treatments increases cell response compared to drug holiday or sustained treatment. To gain insights on these transitions between states of vulnerability to cell death, we developed a compartmental model explaining the emergence of drug-tolerant cell populations, and the fluxes between drug-sensitivity states. We found that drug-sensitivity states coexist in a clonal population of cancer cells with continuous transitions between them, which are sufficient to explain both the sustained resistance to repeated treatments and how alternating drug treatments ameliorates the overall treatment efficacy.<\/jats:p>","DOI":"10.1038\/s44320-025-00150-0","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:04:18Z","timestamp":1759309458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Transition between cell states of sensitivity reveals molecular vulnerability of drug-tolerant cells"],"prefix":"10.1038","volume":"21","author":[{"given":"Ludovic","family":"Peyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7723-9365","authenticated-orcid":false,"given":"Marielle","family":"P\u00e9r\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Moureau-Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Djema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0422-9182","authenticated-orcid":false,"given":"Bernard","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1149-7716","authenticated-orcid":false,"given":"Georges","family":"Vassaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5712-8660","authenticated-orcid":false,"given":"J\u00e9r\u00e9mie","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"150_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molcel.2008.02.012","volume":"30","author":"JG Albeck","year":"2008","unstructured":"Albeck JG, Burke JM, Aldridge BB, Zhang M, Lauffenburger DA, Sorger PK (2008) Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol Cell 30:11\u201325","journal-title":"Mol Cell"},{"key":"150_CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3934\/mbe.2012.9.241","volume":"9","author":"MV Barbarossa","year":"2012","unstructured":"Barbarossa MV, Kuttler C, Zinsl J (2012) Delay equations modeling the effects of phase-specific drugs and immunotherapy on proliferating tumor cells. Math Biosci Eng 9:241\u2013257","journal-title":"Math Biosci Eng"},{"key":"150_CR3","doi-asserted-by":"crossref","first-page":"e1003800","DOI":"10.1371\/journal.pcbi.1003800","volume":"10","author":"S Benzekry","year":"2014","unstructured":"Benzekry S, Lamont C, Beheshti A, Tracz A, Ebos JML, Hlatky L, Hahnfeldt P (2014) Classical mathematical models for description and prediction of experimental tumor growth. PLoS Comput Biol 10:e1003800","journal-title":"PLoS Comput Biol"},{"key":"150_CR4","doi-asserted-by":"crossref","first-page":"e1003893","DOI":"10.1371\/journal.pcbi.1003893","volume":"10","author":"F Bertaux","year":"2014","unstructured":"Bertaux F, Stoma S, Drasdo D, Batt G (2014) Dynamics of cell-to-cell variability in TRAIL-induced apoptosis explains fractional killing and predicts reversible resistance. PLoS Comput Biol 10:e1003893.","journal-title":"PLoS Comput Biol"},{"key":"150_CR5","doi-asserted-by":"crossref","first-page":"101600","DOI":"10.1016\/j.xpro.2022.101600","volume":"3","author":"B Bian","year":"2022","unstructured":"Bian B, Paquet A, Arguel M-J, Meyer M, Peyre L, Chalabi A, P\u00e9r\u00e9 M, Lebrigand K, Waldmann R, Barbry P et al (2022) Coupling live-cell imaging and in situ isolation of the same single cell to profile the transient states of predicted drug-tolerant cells. STAR Protoc 3:101600","journal-title":"STAR Protoc"},{"key":"150_CR6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3934\/dcdsb.2013.18.865","volume":"18","author":"F Billy","year":"2013","unstructured":"Billy F, Clairambault J (2013) Designing proliferating cell population models with functional targets for control by anti-cancer drugs. Discrete Contin Dyn Syst 18:865\u2013889","journal-title":"Discrete Contin Dyn Syst"},{"key":"150_CR7","doi-asserted-by":"crossref","first-page":"jcs261400","DOI":"10.1242\/jcs.261400","volume":"137","author":"JH Buss","year":"2024","unstructured":"Buss JH, Begnini KR, Lenz G (2024) The contribution of asymmetric cell division to phenotypic heterogeneity in cancer. J Cell Sci 137:jcs261400","journal-title":"J Cell Sci"},{"key":"150_CR8","doi-asserted-by":"crossref","first-page":"jcs260103","DOI":"10.1242\/jcs.260103","volume":"136","author":"JH Buss","year":"2023","unstructured":"Buss JH, Lenz LS, Pereira LC, Torgo D, Marcolin J, Begnini KR, Lenz G (2023) The role of mitosis in generating fitness heterogeneity. J Cell Sci 136:jcs260103","journal-title":"J Cell Sci"},{"key":"150_CR9","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/j.bbagen.2016.06.009","volume":"1860","author":"RH Chisholm","year":"2016","unstructured":"Chisholm RH, Lorenzi T, Clairambault J (2016) Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation. Biochim Biophys Acta 1860:2627\u20132645","journal-title":"Biochim Biophys Acta"},{"key":"150_CR10","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/1535-7163.MCT-06-0379","volume":"5","author":"M-K Choo","year":"2006","unstructured":"Choo M-K, Kawasaki N, Singhirunnusorn P, Koizumi K, Sato S, Akira S, Saiki I, Sakurai H (2006) Blockade of transforming growth factor-\u03b2-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade. Mol Cancer Ther 5:2970\u20132976","journal-title":"Mol Cancer Ther"},{"key":"150_CR11","volume":"15","author":"J Dai","year":"2024","unstructured":"Dai J, Zheng S, Falco MM, Bao J, Eriksson J, Pikkusaari S, Forst\u00e9n S, Jiang J, Wang W, Gao L et al (2024) Tracing back primed resistance in cancer via sister cells. Nat Commun 15:1158","journal-title":"Nat Commun"},{"key":"150_CR12","doi-asserted-by":"crossref","unstructured":"Denis CM & Fran\u00e7ois P (2024) Unclocklike Oscillators with Frequency Memory for the Entrainment of Biological Clocks. PRX Life 2:043008","DOI":"10.1103\/PRXLife.2.043008"},{"key":"150_CR13","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/cdd.2013.94","volume":"20","author":"Y Dondelinger","year":"2013","unstructured":"Dondelinger Y, Aguileta MA, Goossens V, Dubuisson C, Grootjans S, Dejardin E, Vandenabeele P, Bertrand MJM (2013) RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1\/2 depletion or TAK1 kinase inhibition. Cell Death Differ 20:1381\u20131392","journal-title":"Cell Death Differ"},{"key":"150_CR14","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1177\/1535370216661779","volume":"241","author":"M El-Mesery","year":"2016","unstructured":"El-Mesery M, Shaker ME, Elgaml A (2016) The SMAC mimetic BV6 induces cell death and sensitizes different cell lines to TNF-\u03b1 and TRAIL-induced apoptosis. Exp Biol Med 241:2015\u20132022","journal-title":"Exp Biol Med"},{"key":"150_CR15","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.cellsig.2007.05.016","volume":"19","author":"S Feng","year":"2007","unstructured":"Feng S, Yang Y, Mei Y, Ma L, Zhu D, Hoti N, Castanares M, Wu M (2007) Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 19:2056\u20132067","journal-title":"Cell Signal"},{"key":"150_CR16","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1091\/mbc.e12-10-0737","volume":"24","author":"DA Flusberg","year":"2013","unstructured":"Flusberg DA, Roux J, Spencer SL, Sorger PK (2013) Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes. Mol Biol Cell 24:2186\u20132200","journal-title":"Mol Biol Cell"},{"key":"150_CR17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW et al (2018) Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 25:486\u2013541","journal-title":"Cell Death Differ"},{"key":"150_CR18","doi-asserted-by":"crossref","first-page":"e1002556","DOI":"10.1371\/journal.pcbi.1002556","volume":"8","author":"P Gerlee","year":"2012","unstructured":"Gerlee P, Nelander S (2012) The impact of phenotypic switching on glioblastoma growth and invasion. PLoS Comput Biol 8:e1002556","journal-title":"PLoS Comput Biol"},{"key":"150_CR19","doi-asserted-by":"crossref","DOI":"10.1038\/s41540-025-00511-3","volume":"11","author":"JL Gevertz","year":"2025","unstructured":"Gevertz JL, Greene JM, Prosperi S, Comandante-Lou N, Sontag ED (2025) Understanding therapeutic tolerance through a mathematical model of drug-induced resistance. Npj Syst Biol Appl 11:30","journal-title":"Npj Syst Biol Appl"},{"key":"150_CR20","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, Cheng H, Jin K, Ni Q, Yu X et al (2019) The role of necroptosis in cancer biology and therapy. Mol Cancer 18:100","journal-title":"Mol Cancer"},{"key":"150_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.devcel.2016.04.018","volume":"37","author":"ML Goodall","year":"2016","unstructured":"Goodall ML, Fitzwalter BE, Zahedi S, Wu M, Rodriguez D, Mulcahy-Levy JM, Green DR, Morgan M, Cramer SD, Thorburn A (2016) The autophagy machinery controls cell death switching between apoptosis and necroptosis. Dev Cell 37:337\u2013349","journal-title":"Dev Cell"},{"key":"150_CR22","doi-asserted-by":"crossref","first-page":"110162","DOI":"10.1016\/j.jtbi.2020.110162","volume":"490","author":"EB Gunnarsson","year":"2020","unstructured":"Gunnarsson EB, De S, Leder K, Foo J (2020) Understanding the role of phenotypic switching in cancer drug resistance. J Theor Biol 490:110162","journal-title":"J Theor Biol"},{"key":"150_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2016.05.036","volume":"380","author":"S Hannes","year":"2016","unstructured":"Hannes S, Abhari BA, Fulda S (2016) Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked. Cancer Lett 380:31\u201338","journal-title":"Cancer Lett"},{"key":"150_CR24","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04014-x","volume":"12","author":"S Hannes","year":"2021","unstructured":"Hannes S, Karlowitz R, van Wijk SJL (2021) The Smac mimetic BV6 cooperates with STING to induce necroptosis in apoptosis-resistant pancreatic carcinoma cells. Cell Death Dis 12:816","journal-title":"Cell Death Dis"},{"key":"150_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41811-8","volume":"14","author":"G Harmange","year":"2023","unstructured":"Harmange G, Hueros RAR, Schaff DL, Emert B, Saint-Antoine M, Kim LC, Niu Z, Nellore S, Fane ME, Alicea GM et al (2023) Disrupting cellular memory to overcome drug resistance. Nat Commun 14:7130","journal-title":"Nat Commun"},{"key":"150_CR26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4161\/auto.4592","volume":"3","author":"X Hu","year":"2007","unstructured":"Hu X, Han W, Li L (2007) Targeting the weak point of cancer by induction of necroptosis. Autophagy 3:490\u2013492","journal-title":"Autophagy"},{"key":"150_CR27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2007.11.007","volume":"259","author":"X Hu","year":"2008","unstructured":"Hu X, Xuan Y (2008) Bypassing cancer drug resistance by activating multiple death pathways \u2013 a proposal from the study of circumventing cancer drug resistance by induction of necroptosis. Cancer Lett 259:127\u2013137","journal-title":"Cancer Lett"},{"key":"150_CR28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13046-018-0976-z","volume":"37","author":"X Huang","year":"2018","unstructured":"Huang X, Xiao F, Li Y, Qian W, Ding W, Ye X (2018) Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia. J Exp Clin Cancer Res 37:310","journal-title":"J Exp Clin Cancer Res"},{"key":"150_CR29","doi-asserted-by":"crossref","first-page":"107845","DOI":"10.1016\/j.celrep.2020.107845","volume":"32","author":"Z Inde","year":"2020","unstructured":"Inde Z, Forcina GC, Denton K, Dixon SJ (2020) Kinetic heterogeneity of cancer cell fractional killing. Cell Rep 32:107845","journal-title":"Cell Rep"},{"key":"150_CR30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3390\/biom12030348","volume":"12","author":"P Jain","year":"2022","unstructured":"Jain P, Bhatia S, Thompson EW, Jolly MK (2022) Population dynamics of epithelial-mesenchymal heterogeneity in cancer cells. Biomolecules 12:348","journal-title":"Biomolecules"},{"key":"150_CR31","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/14737140.2018.1527689","volume":"18","author":"AM Jarrett","year":"2018","unstructured":"Jarrett AM, Lima EABF, Hormuth DA, McKenna MT, Feng X, Ekrut DA, Resende ACM, Brock A, Yankeelov TE (2018) Mathematical models of tumor cell proliferation: a review of the literature. Expert Rev Anticancer Ther 18:1271\u20131286","journal-title":"Expert Rev Anticancer Ther"},{"key":"150_CR32","doi-asserted-by":"crossref","first-page":"e1012073","DOI":"10.1371\/journal.pcbi.1012073","volume":"20","author":"K Jitmana","year":"2024","unstructured":"Jitmana K, Griffiths JI, Fereday S, DeFazio A, Bowtell D (2024) Mathematical modeling of the evolution of resistance and aggressiveness of high-grade serous ovarian cancer from patient CA-125 time series. PLoS Comput Biol 20:e1012073","journal-title":"PLoS Comput Biol"},{"key":"150_CR33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neo.2021.03.003","volume":"23","author":"A Koch","year":"2021","unstructured":"Koch A, Jeiler B, Roedig J, Van Wijk SJL, Dolgikh N, Fulda S (2021) Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt\u2019s lymphoma cell lines. Neoplasia 23:539\u2013550","journal-title":"Neoplasia"},{"key":"150_CR34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nrclinonc.2013.158","volume":"10","author":"EA Kuczynski","year":"2013","unstructured":"Kuczynski EA, Sargent DJ, Grothey A, Kerbel RS (2013) Drug rechallenge and treatment beyond progression\u2014implications for drug resistance. Nat Rev Clin Oncol 10:571\u2013587","journal-title":"Nat Rev Clin Oncol"},{"key":"150_CR35","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s12551-021-00858-x","volume":"13","author":"P Kulkarni","year":"2021","unstructured":"Kulkarni P, Achuthan S, Bhattacharya S, Jolly MK, Kotnala S, Leite VBP, Mohanty A, Orban J, Roy S, Rangarajan G et al (2021) Protein conformational dynamics and phenotypic switching. Biophys Rev 13:1127\u20131138","journal-title":"Biophys Rev"},{"key":"150_CR36","volume":"9","author":"N Kumar","year":"2019","unstructured":"Kumar N, Cramer GM, Dahaj SAZ, Sundaram B, Celli JP, Kulkarni RV (2019) Stochastic modeling of phenotypic switching and chemoresistance in cancer cell populations. Sci Rep 9:10845","journal-title":"Sci Rep"},{"key":"150_CR37","volume":"52","author":"L Liu","year":"2019","unstructured":"Liu L, Fan J, Ai G, Liu J, Luo N, Li C, Cheng Z (2019) Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells. Biol Res 52:37","journal-title":"Biol Res"},{"key":"150_CR38","doi-asserted-by":"crossref","first-page":"e8620","DOI":"10.1371\/journal.pone.0008620","volume":"5","author":"JM Lluis","year":"2010","unstructured":"Lluis JM, Nachbur U, Cook WD, Gentle IE, Moujalled D, Moulin M, Wong WW-L, Khan N, Chau D, Callus BA et al (2010) TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-\u03baB dependent induction of cFLIPL. PLoS ONE 5:e8620","journal-title":"PLoS ONE"},{"key":"150_CR39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41588-020-0645-y","volume":"52","author":"Z Meir","year":"2020","unstructured":"Meir Z, Mukamel Z, Chomsky E, Lifshitz A, Tanay A (2020) Single-cell analysis of clonal maintenance of transcriptional and epigenetic states in cancer cells. Nat Genet 52:709\u2013718","journal-title":"Nat Genet"},{"key":"150_CR40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cels.2020.08.019","volume":"11","author":"M Meyer","year":"2020","unstructured":"Meyer M, Paquet A, Arguel M-J, Peyre L, Gomes-Pereira LC, Lebrigand K, Mograbi B, Brest P, Waldmann R, Barbry P et al (2020) Profiling the non-genetic origins of cancer drug resistance with a single-cell functional genomics approach using predictive cell dynamics. Cell Syst 11:367\u2013374.e5","journal-title":"Cell Syst"},{"key":"150_CR41","doi-asserted-by":"crossref","unstructured":"Miao B, Degterev A (2009) Methods to analyze cellular necroptosis. In: Erhardt P, Toth A (eds) Apoptosis. Humana Press, Totowa, pp 79\u201393","DOI":"10.1007\/978-1-60327-017-5_6"},{"key":"150_CR42","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/cdd.2014.123","volume":"21","author":"SR Mihaly","year":"2014","unstructured":"Mihaly SR, Ninomiya-Tsuji J, Morioka S (2014) TAK1 control of cell death. Cell Death Differ 21:1667\u20131676","journal-title":"Cell Death Differ"},{"key":"150_CR43","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-02879-y","volume":"11","author":"MA Miles","year":"2020","unstructured":"Miles MA, Hawkins CJ (2020) In vitro analysis reveals necroptotic signaling does not provoke DNA damage or HPRT mutations. Cell Death Dis 11:680","journal-title":"Cell Death Dis"},{"key":"150_CR44","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","volume":"35","author":"RM Mohammad","year":"2015","unstructured":"Mohammad RM, Muqbil I, Lowe L, Yedjou C, Hsu H-Y, Lin L-T, Siegelin MD, Fimognari C, Kumar NB, Dou QP et al (2015) Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol 35:S78\u2013S103","journal-title":"Semin Cancer Biol"},{"key":"150_CR45","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.3390\/ijms24054923","volume":"24","author":"M Montagnani Marelli","year":"2023","unstructured":"Montagnani Marelli M, Beretta G, Moretti RM (2023) Necroptosis induced by delta-tocotrienol overcomes docetaxel chemoresistance in prostate cancer cells. Int J Mol Sci 24:4923","journal-title":"Int J Mol Sci"},{"key":"150_CR46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1083\/jcb.201305070","volume":"204","author":"S Morioka","year":"2014","unstructured":"Morioka S, Broglie P, Omori E, Ikeda Y, Takaesu G, Matsumoto K, Ninomiya-Tsuji J (2014) TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation. J Cell Biol 204:607\u2013623","journal-title":"J Cell Biol"},{"key":"150_CR47","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/onc.2009.110","volume":"28","author":"S Morioka","year":"2009","unstructured":"Morioka S, Omori E, Kajino T, Kajino-Sakamoto R, Matsumoto K, Ninomiya-Tsuji J (2009a) TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP. Oncogene 28:2257\u20132265","journal-title":"Oncogene"},{"key":"150_CR48","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/onc.2009.110","volume":"28","author":"S Morioka","year":"2009","unstructured":"Morioka S, Omori E, Kajino T, Kajino-Sakamoto R, Matsumoto K, Ninomiya-Tsuji J (2009b) TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP. Oncogene 28:2257\u20132265","journal-title":"Oncogene"},{"key":"150_CR49","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1073\/pnas.1916427117","volume":"117","author":"MG Naito","year":"2020","unstructured":"Naito MG, Xu D, Amin P, Lee J, Wang H, Li W, Kelliher M, Pasparakis M, Yuan J (2020) Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke. Proc Natl Acad Sci USA 117:4959\u20134970","journal-title":"Proc Natl Acad Sci USA"},{"key":"150_CR50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/biom12010008","volume":"12","author":"A Nam","year":"2021","unstructured":"Nam A, Mohanty A, Bhattacharya S, Kotnala S, Achuthan S, Hari K, Srivastava S, Guo L, Nathan A, Chatterjee R et al (2021) Dynamic phenotypic switching and group behavior help non-small cell lung cancer cells evade chemotherapy. Biomolecules 12:8","journal-title":"Biomolecules"},{"key":"150_CR51","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6300-2","volume":"19","author":"D Niveditha","year":"2019","unstructured":"Niveditha D, Sharma H, Majumder S, Mukherjee S, Chowdhury R, Chowdhury S (2019) Transcriptomic analysis associated with reversal of cisplatin sensitivity in drug resistant osteosarcoma cells after a drug holiday. BMC Cancer 19:1045","journal-title":"BMC Cancer"},{"key":"150_CR52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature09852","volume":"471","author":"A Oberst","year":"2011","unstructured":"Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS, Green DR (2011) Catalytic activity of the caspase-8\u2013FLIPL complex inhibits RIPK3-dependent necrosis. Nature 471:363\u2013367","journal-title":"Nature"},{"key":"150_CR53","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2016.03.025","volume":"165","author":"AL Paek","year":"2016","unstructured":"Paek AL, Liu JC, Loewer A, Forrester WC, Lahav G (2016) Cell-to-cell variation in p53 dynamics leads to fractional killing. Cell 165:631\u2013642","journal-title":"Cell"},{"key":"150_CR54","first-page":"46","volume":"55","author":"M P\u00e9r\u00e9","year":"2022","unstructured":"P\u00e9r\u00e9 M, Oyarzun D, Roux J, Chaves M (2022) Modeling isogenic cancer cell response upon varying TRAIL stimulations to decipher the kinetic determinants of cell fate decision. IFAC-Pap 55:46\u201351","journal-title":"IFAC-Pap"},{"key":"150_CR55","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3467","volume":"4","author":"AO Pisco","year":"2013","unstructured":"Pisco AO, Brock A, Zhou J, Moor A, Mojtahedi M, Jackson D, Huang S (2013) Non-Darwinian dynamics in therapy-induced cancer drug resistance. Nat Commun 4:2467","journal-title":"Nat Commun"},{"key":"150_CR56","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","volume":"174","author":"F Rambow","year":"2018","unstructured":"Rambow F, Rogiers A, Marin-Bejar O, Aibar S, Femel J, Dewaele M, Karras P, Brown D, Chang YH, Debiec-Rychter M et al (2018) Toward minimal residual disease-directed therapy in melanoma. Cell 174:843\u2013855.e19","journal-title":"Cell"},{"key":"150_CR57","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10690","volume":"7","author":"M Ramirez","year":"2016","unstructured":"Ramirez M, Rajaram S, Steininger RJ, Osipchuk D, Roth MA, Morinishi LS, Evans L, Ji W, Hsu C-H, Thurley K et al (2016) Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells. Nat Commun 7:10690","journal-title":"Nat Commun"},{"key":"150_CR58","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s12094-019-02267-9","volume":"22","author":"DA Ron","year":"2020","unstructured":"Ron DA, Vera R, Labandeira CM, Manrique MCA, N\u00fa\u00f1ez M\u00c1, Cid NG, Mata JG, Montes AF (2020) Maintenance treatment in metastatic colorectal cancer: in search of the best strategy. Clin Transl Oncol 22:1205\u20131215","journal-title":"Clin Transl Oncol"},{"key":"150_CR59","doi-asserted-by":"crossref","first-page":"803","DOI":"10.15252\/msb.20145584","volume":"11","author":"J Roux","year":"2015","unstructured":"Roux J, Hafner M, Bandara S, Sims JJ, Hudson H, Chai D, Sorger PK (2015) Fractional killing arises from cell\u2010to\u2010cell variability in overcoming a caspase activity threshold. Mol Syst Biol 11:803","journal-title":"Mol Syst Biol"},{"key":"150_CR60","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41588-022-01105-z","volume":"54","author":"M Russo","year":"2022","unstructured":"Russo M, Pompei S, Sogari A, Corigliano M, Crisafulli G, Puliafito A, Lamba S, Erriquez J, Bertotti A, Gherardi M et al (2022) A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells. Nat Genet 54:976\u2013984","journal-title":"Nat Genet"},{"key":"150_CR61","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature22794","volume":"546","author":"SM Shaffer","year":"2017","unstructured":"Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, Beqiri M, Sproesser K, Brafford PA, Xiao M et al (2017) Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546:431\u2013435","journal-title":"Nature"},{"key":"150_CR62","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cell.2020.07.003","volume":"182","author":"SM Shaffer","year":"2020","unstructured":"Shaffer SM, Emert BL, Reyes Hueros RA, Cote C, Harmange G, Schaff DL, Sizemore AE, Gupte R, Torre E, Singh A et al (2020) Memory sequencing reveals heritable single-cell gene expression programs associated with distinct cellular behaviors. Cell 182:947\u2013959.e17","journal-title":"Cell"},{"key":"150_CR63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","volume":"141","author":"SV Sharma","year":"2010","unstructured":"Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA et al (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141:69\u201380","journal-title":"Cell"},{"key":"150_CR64","doi-asserted-by":"crossref","unstructured":"Simeoni C, Dinicola S, Cucina A, Mascia C, Bizzarri M (2018) Systems biology approach and mathematical modeling for analyzing phase-space switch during epithelial-mesenchymal transition. In: Bizzarri M (ed) Systems biology. Springer, New York, pp 95\u2013123","DOI":"10.1007\/978-1-4939-7456-6_7"},{"key":"150_CR65","doi-asserted-by":"crossref","first-page":"1050516","DOI":"10.3389\/fmicb.2022.1050516","volume":"13","author":"A Singh","year":"2023","unstructured":"Singh A, Saint-Antoine M (2023) Probing transient memory of cellular states using single-cell lineages. Front Microbiol 13:1050516","journal-title":"Front Microbiol"},{"key":"150_CR66","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature08012","volume":"459","author":"SL Spencer","year":"2009","unstructured":"Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK (2009) Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459:428\u2013432","journal-title":"Nature"},{"key":"150_CR67","doi-asserted-by":"crossref","first-page":"20140079","DOI":"10.1098\/rsif.2014.0079","volume":"11","author":"T Stiehl","year":"2014","unstructured":"Stiehl T, Baran N, Ho AD, Marciniak-Czochra A (2014) Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse. J R Soc Interface 11:20140079","journal-title":"J R Soc Interface"},{"key":"150_CR68","doi-asserted-by":"crossref","first-page":"eabi7711","DOI":"10.1126\/sciadv.abi7711","volume":"8","author":"X Sun","year":"2022","unstructured":"Sun X, Bieber JM, Hammerlindl H, Chalkley RJ, Li KH, Burlingame AL, Jacobson MP, Wu LF, Altschuler SJ (2022) Modulating environmental signals to reveal mechanisms and vulnerabilities of cancer persisters. Sci Adv 8:eabi7711","journal-title":"Sci Adv"},{"key":"150_CR69","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.immuni.2020.04.010","volume":"52","author":"B Tummers","year":"2020","unstructured":"Tummers B, Mari L, Guy CS, Heckmann BL, Rodriguez DA, R\u00fchl S, Moretti J, Crawford JC, Fitzgerald P, Kanneganti T-D et al (2020) Caspase-8-dependent inflammatory responses are controlled by its adaptor, FADD, and necroptosis. Immunity 52:994\u20131006.e8","journal-title":"Immunity"},{"key":"150_CR70","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.tranon.2019.11.011","volume":"13","author":"Q Wang","year":"2020","unstructured":"Wang Q, Wang P, Zhang L, Tessema M, Bai L, Xu X, Li Q, Zheng X, Saxton B, Chen W et al (2020) Epigenetic regulation of RIP3 suppresses necroptosis and increases resistance to chemotherapy in nonsmall cell lung cancer. Transl Oncol 13:372\u2013382","journal-title":"Transl Oncol"},{"key":"150_CR71","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.7150\/ijbs.27854","volume":"14","author":"Y Wang","year":"2018","unstructured":"Wang Y, Hao F, Nan Y, Qu L, Na W, Jia C, Chen X (2018) PKM2 inhibitor Shikonin overcomes the cisplatin resistance in bladder cancer by inducing necroptosis. Int J Biol Sci 14:1883\u20131891","journal-title":"Int J Biol Sci"},{"key":"150_CR72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbcan.2017.04.001","volume":"1867","author":"DJ Wooten","year":"2017","unstructured":"Wooten DJ, Quaranta V (2017) Mathematical models of cell phenotype regulation and reprogramming: make cancer cells sensitive again! Biochim Biophys Acta Rev Cancer 1867:167\u2013175","journal-title":"Biochim Biophys Acta Rev Cancer"}],"container-title":["Molecular Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44320-025-00150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44320-025-00150-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44320-025-00150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T10:47:34Z","timestamp":1785926854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44320-025-00150-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":72,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,2]]}},"alternative-id":["150"],"URL":"https:\/\/doi.org\/10.1038\/s44320-025-00150-0","relation":{},"ISSN":["1744-4292"],"issn-type":[{"value":"1744-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"4"}}